The IHC experiment not only validated the gain of expression of STC2 in osteosarcoma (95.3%) comparing to adjacent control samples (< 10%), but also shown an inspiring fact that a big portion of samples were nuclear staining (92.7%) which is a different stain pattern than the previous location prediction result. The gene discussed is STC2; the disease is osteosarcoma.